Abstract:Adenoviral vectors are the most widely used vectors in gene therapy, largely owing to their high efficacy in gene delivery and the ability to transduce a broad variety of cell types. Although more than 60 human adenoviruses types have been identified, the majority of recombinant adenoviral vectors (AdVs) is based on a small fraction of adenovirus types (Ad2 and 5 from species C) and their genetic modification. Predefined tissue tropism and preexisting immunity considerably limit the application of currently used vectors, making the developing of alternative AdV s mandatory. However, generation of AdVs other than species C was hampered by the lack of convenient cloning methods, for traditional approaches were limited by the low efficiency and complicate procedure. We believe that the engineered adenovirus-library is going to provide spacious novel view to the adenovirus field. As a toolkit, it will bring the AdVs from mono- to multi-types and enables broader applications in molecular medicine including gene therapy and vaccination studies, as well as basic virology studies. Recombineering techniques provide powerful tools for arbitrary engineering of recombinant DNA. Here we established a seamless recombineering pipeline for high-throughput cloning and tagging of adenoviral genomes. We amplified and purified wild type adenoviruses that represent all seven human adenovirus species. Using the recombineering pipeline we generated an engineered adenovirus-library including around half of the currently available adenovirus types. To prove integrity of the cloned adenovirus genomes we performed rescue experiments in respective cell lines permissive for adenovirus infection and we optimized rescue condition by testing different molecular forms of the adenoviral DNA (linear, circular, precise release of the DNA molecule). A limited number of selected types from each species will be tagged with a P2A peptide-mediated bicistronic-expression cassette providing a Turbo Green fluorescent protein as in vitro marker and a NanoLuc luciferase for in vivo studies. These tagged adenoviral vectors will be evaluated in cultured cell lines and mouse model. A summary of the human adenoviral vector-library which can be used for further genetic modification and tagging based on the recombineering technology is shown in figure 1. We believe that the engineered adenovirus-library is going to provide spacious novel view to the adenovirus field. As a toolkit, it will bring the AdVs from mono- to multitypes and enables broader applications in molecular medicine including gene therapy and vaccination studies, as well as basic virology studies.

271. Full-Length Antibody Therapy Mediated by Adenovirus in Rodent and Non-Primate Animal Models

705. A New Strategy for Cancer Therapy: Application of Adenovirus-Mediated Complete-Length Antibody Gene

Gene Therapy Using Adenovirus-Mediated Full-Length Anti-Her-2 Antibody For Her-2 Overexpression Cancers

Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey.

Progress in systemic administration of adenovirus vector for cancer gene therapy

Cancer Gene Therapy of Adenovirus-Mediated Anti-4-1bb Scfv in Immunocompetent Mice

Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner

A Novel Immunocompetent Murine Tumor Model for the Evaluation of RCAd-enhanced RDAd Transduction Efficacy

Oncolytic Adenovirus Programmed by Synthetic Gene Circuit for Cancer Immunotherapy

Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy

48. High-Throughput Cloning and Tagging of an Engineered Adenovirus-Library Empowers Vector Diversity for Broad Applications

Combinational Adenovirus-Mediated Gene Therapy and Dendritic Cell Vaccine in Combating Well-Established Tumors

Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses

Advances in Research on Adenovirus Nanocomplexes for Tumor Therapy

[Gene Expression of Tumor Cells Both in Vitro and in Vivo Enhanced by Integrin-Targeting Adenovirus Vector].

Full Remission of CAR-Deficient Tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus

Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression

Adeno-associated virus vector as a platform for gene therapy delivery

Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System

Adenoviral vector-based strategies against infectious disease and cancer

Adjuvant Effect of HER-2/neu-specific Adenoviral Vector Stimulating CD8⁺ T and Natural Killer Cell Responses on Anti-Her-2/neu Antibody Therapy for Well-Established Breast Tumors in HER-2/neu Transgenic Mice.